IRAK4-IN-21 |
Catalog No.GC69288 |
IRAK4-IN-21 (compuesto 17) es un inhibidor oral altamente efectivo y selectivo de IRAK4, con valores de IC50 de 5 y 56 nM para IRAK4 y TAK1 respectivamente. IRAK4-IN-21 puede inhibir eficazmente la producción de IL-23 (IC50=0.17 µM), lo que lo hace útil en la investigación de enfermedades autoinmunitarias como psoriasis en placas y artritis psoriásica.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170694-04-7
Sample solution is provided at 25 µL, 10mM.
Review for IRAK4-IN-21
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for IRAK4-IN-21
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *